EpimedX Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

EpimedX General Information


Operator of a research and development company intended to develop gene regulation technology. The company's research and development services include developing gene regulation therapy which helps in treatment for sickle cell disease, beta-thalassemia and malaria, enabling patients to avail a safe, cost-effective and permanent treatment for sickle cell disease, beta-thalassemia, and malaria without dangerous or harmful side effects.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 755 Research Parkway
  • Suite 452
  • Oklahoma City, OK 73104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EpimedX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 01-Oct-2017 00.00 Completed Out of Business
10. Grant 01-Mar-2017 00.00 Completed Startup
9. Angel (individual) 06-May-2015 00.00 Completed Startup
8. Grant 01-Jan-2015 00000 00.00 Completed Startup
7. Early Stage VC 03-Sep-2014 00000 00.00 Completed Startup
6. Angel (individual) 19-Feb-2014 00.00 Completed Startup
5. Angel (individual) 16-Oct-2013 00.00 Completed Startup
4. Grant 01-Feb-2013 00000 00.00 Completed Startup
3. Grant $750K $7.5M Completed Startup
2. Angel (individual) 31-Dec-2012 $7.5M $7.5M 00.000 Completed Startup
To view EpimedX’s complete valuation and funding history, request access »

EpimedX Executive Team (4)

Name Title Board Seat Contact Info
Visar Belegu Ph.D Co-Founder & Board Member
You’re viewing 1 of 4 executive team members. Get the full list »

EpimedX Board Members (1)

Name Representing Role Since
Visar Belegu Ph.D EpimedX Co-Founder & Board Member 000 0000
To view EpimedX’s complete board members history, request access »